Drug intelligence / Profile preview

STING-NP

Development stage
Preclinical
Lead developer
Vanderbilt University
Modality
Nanoparticles → Drug Delivery Systems
Administration
Intratumoral
01

Overview

STING-NP is a nanoparticle-based immunotherapy designed to activate the Stimulator of Interferon Genes (STING) pathway. It consists of polymer vesicles (polymersomes) engineered for the efficient cytosolic delivery of 2’3’ cyclic guanosine monophosphate-adenosine monophosphate (cGAMP), an endogenous cyclic dinucleotide (CDN) ligand. By overcoming the delivery barriers of free CDNs—such as poor membrane permeability and rapid enzymatic degradation—STING-NP enhances the activation of innate immunity within the tumor microenvironment. Preclinical studies, particularly in murine melanoma models, have shown that intratumoral administration of STING-NP increases tumor immunogenicity and works synergistically with immune checkpoint inhibitors (anti-PD-1/CTLA-4) to promote systemic anti-tumor responses and overcome immune escape mechanisms.

Other names
STING-activating nanoparticles
02

Targets

STING (Stimulator of interferon genes protein)

Beyond the preview

Go deeper on STING-NP.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on STING-NP.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call